1. Home
  2. BBY vs JAZZ Comparison

BBY vs JAZZ Comparison

Compare BBY & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Best Buy Co. Inc.

BBY

Best Buy Co. Inc.

HOLD

Current Price

$57.46

Market Cap

12.9B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$210.63

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBY
JAZZ
Founded
1966
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
10.4B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
BBY
JAZZ
Price
$57.46
$210.63
Analyst Decision
Buy
Strong Buy
Analyst Count
19
14
Target Price
$76.28
$217.57
AVG Volume (30 Days)
3.0M
814.8K
Earning Date
05-28-2026
05-05-2026
Dividend Yield
6.54%
N/A
EPS Growth
17.76
N/A
EPS
5.04
N/A
Revenue
$41,691,000,000.00
$1,618,693,000.00
Revenue This Year
$1.15
$6.22
Revenue Next Year
$1.38
$7.68
P/E Ratio
$11.44
N/A
Revenue Growth
0.39
N/A
52 Week Low
$57.52
$105.00
52 Week High
$84.99
$208.15

Technical Indicators

Market Signals
Indicator
BBY
JAZZ
Relative Strength Index (RSI) 34.76 66.87
Support Level N/A $194.77
Resistance Level $67.51 N/A
Average True Range (ATR) 1.86 5.01
MACD -0.53 0.38
Stochastic Oscillator 7.55 99.95

Price Performance

Historical Comparison
BBY
JAZZ

About BBY Best Buy Co. Inc.

With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: